Lilly Endowment Inc - Net Worth and Insider Trading
Lilly Endowment Inc Net Worth
The estimated net worth of Lilly Endowment Inc is at least $53.7 Billion dollars as of 2023-09-30. Lilly Endowment Inc is the 10% Owner of Eli Lilly and Co and owns about 99,983,810 shares of Eli Lilly and Co (LLY) stock worth over $53.7 Billion. Details can be seen in Lilly Endowment Inc's Latest Holdings Summary section.
Transaction Summary of Lilly Endowment Inc
Lilly Endowment Inc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lilly Endowment Inc owns 1 companies in total, including Eli Lilly and Co (LLY) .
Click here to see the complete history of Lilly Endowment Inc’s form 4 insider trades.
Insider Ownership Summary of Lilly Endowment Inc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LLY | Eli Lilly and Co | 2003-07-31 | 10 percent owner |
Lilly Endowment Inc Latest Holdings Summary
Lilly Endowment Inc currently owns a total of 1 stock. Lilly Endowment Inc owns 99,983,810 shares of Eli Lilly and Co (LLY) as of September 7, 2023, with a value of $53.7 Billion.
Latest Holdings of Lilly Endowment Inc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co | 2023-09-07 | 99,983,810 | 537.13 | 53,704,303,865 |
Holding Weightings of Lilly Endowment Inc
Lilly Endowment Inc Form 4 Trading Tracker
According to the SEC Form 4 filings, Lilly Endowment Inc has made a total of 165 transactions in Eli Lilly and Co (LLY) over the past 5 years, including 0 buys and 165 sells. The most-recent trade in Eli Lilly and Co is the sale of 210,000 shares on September 7, 2023, which brought Lilly Endowment Inc around $120 Million.
Insider Trading History of Lilly Endowment Inc
- 1
Lilly Endowment Inc Trading Performance
Lilly Endowment Inc Ownership Network
Ownership Network List of Lilly Endowment Inc
Ownership Network Relation of Lilly Endowment Inc
Lilly Endowment Inc Owned Company Details
What does Eli Lilly and Co do?
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Who are the key executives at Eli Lilly and Co?
Lilly Endowment Inc is the 10 percent owner of Eli Lilly and Co. Other key executives at Eli Lilly and Co include EVP & HR & Diversity Eric Dozier , SVP & CEO LoxoONC & Pres LlyONC Naarden Jacob Van , and SVP & ERM & CECO Alonzo Weems .
Eli Lilly and Co (LLY) Insider Trades Summary
Over the past 18 months, Lilly Endowment Inc made 63 insider transaction in Eli Lilly and Co (LLY) with a net sale of 5,266,441. Other recent insider transactions involving Eli Lilly and Co (LLY) include a net sale of 3,800 shares made by Donald A Zakrowski , a net sale of 3,460 shares made by Alonzo Weems , and a net sale of 6,000 shares made by Patrik Jonsson .
In summary, during the past 3 months, insiders sold 1,046,748 shares of Eli Lilly and Co (LLY) in total and bought 0 shares, with a net sale of 1,046,748 shares. During the past 18 months, 5,284,701 shares of Eli Lilly and Co (LLY) were sold and 656 shares were bought by its insiders, resulting in a net sale of 5,284,045 shares.
Eli Lilly and Co (LLY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eli Lilly and Co Insider Transactions
Lilly Endowment Inc Mailing Address
Above is the net worth, insider trading, and ownership report for Lilly Endowment Inc. You might contact Lilly Endowment Inc via mailing address: 2801 North Meridian St, Indianapolis In 46208.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
